Plus Therapeutics (PSTV) Capital Expenditures Growth (5y) (2015 - 2026)
Plus Therapeutics (PSTV) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Plus Therapeutics |
34.26 Mn |
19.15 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
57.65% |
| Dec 31, 2025 |
-11.74% |
| Sep 30, 2025 |
14.04% |
| Jun 30, 2025 |
-10.22% |
| Mar 31, 2025 |
-22.88% |
| Dec 31, 2024 |
-28.53% |
| Sep 30, 2024 |
47.58% |
| Mar 31, 2024 |
46.14% |
| Dec 31, 2023 |
53.06% |
| Sep 30, 2023 |
-27.52% |
| Jun 30, 2023 |
-15.14% |
| Mar 31, 2023 |
12.85% |
| Dec 31, 2022 |
39.77% |
| Sep 30, 2022 |
-28.45% |
| Jun 30, 2022 |
8.92% |
| Mar 31, 2022 |
111.18% |
| Dec 31, 2021 |
17.42% |
| Sep 30, 2021 |
60.95% |
| Jun 30, 2021 |
-16.12% |
| Mar 31, 2021 |
4.01% |
